Li Zhou, Peichen Duan, Pan Zang, Chao Liang, Jianfei Ye, Ye Yan, Shudong Zhang. "Preliminary results from phase II enfortumab vedotin plus toripalimab compared to gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.782